Two genetic testing companies are integrating the workflow of Boston startup FDNA, which makes a suite of apps for clinicians called Face2Gene that use facial analysis, artificial intelligence and genomic insights in hopes of improving diagnoses and treatment of rare diseases. Gaithersburg, Maryland-based GeneDx – which focuses on rare hereditary disorders – and San Francisco, Helsink and Dubai-...
